sofosbuvir

Ukraine

Drugs containing this active substance

  • KYRLED

    The drug is used in combination with other medicinal products for the treatment of adult patients with chronic hepatitis C.

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg

    ATC: J05AP08

    Manufacturer: Strides Pharma Science Limited

  • KYRLED-LP

    The drug is intended for the treatment of adult patients with chronic hepatitis C (CHC).

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Strides Pharma Science Limited

  • MAYHEP

    The drug is used in combination with other medicinal products for the treatment of chronic hepatitis C in adult patients.

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg

    ATC: J05AP08

    Manufacturer: Maylan Laboratories Limited

  • MAYHEP ALL

    The drug is intended for the treatment of chronic hepatitis C virus (HCV) infection in adults.

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg
    velpatasvir 100 mg

    ATC: J05AP55

    Manufacturer: Maylan Laboratories Limited

  • SOFGEN

    The drug is intended for the treatment of adults with chronic hepatitis C. It should be used only in combination with other medicinal products.

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg

    ATC: J05AP08

    Manufacturer: Hetero Labs Limited

  • SOFGEN-L

    The drug is intended for the treatment of chronic hepatitis C in adults and children aged 12 to 18 years.

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Hetero Labs Limited

  • SOFGEN-V

    The drug is intended for the treatment of adults with chronic hepatitis C (HCV).

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg
    velpatasvir 100 mg

    ATC: J05AP55

    Manufacturer: Hetero Labs Limited

  • VELPANUT

    The drug is intended for the treatment of chronic hepatitis C virus (HCV) infection in adults.

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg
    velpatasvir 100 mg

    ATC: J05AP55

    Manufacturer: Nacto Pharma Limited

  • VIRPAS

    It is indicated for the treatment of adult patients with chronic hepatitis C (CHC).

    Form: tablets, film-coated

    Active substance Dosage
    ledipasvir 90 mg
    sofosbuvir 400 mg

    ATC: J05AP51

    Manufacturer: Strides Pharma Science Limited

  • VIRSO

    The drug is used in combination with other medicinal products for the treatment of adult patients with chronic hepatitis C (HCV).

    Form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg

    ATC: J05AP08

    Manufacturer: Strides Pharma Science Limited